Both in Pharmaceuticals
Enliven Therapeutics vs Viridian Therapeutics
Over the past year ELVN returned +148.6% and VRDN returned +28.8%; their daily moves had a correlation of 0.21.
ELVN +148.6% VRDN +28.8%Growth of $1, one year, split-adjusted
| Metric | ELVN | VRDN |
|---|---|---|
| Price | $47.25 | $29.06 |
| Market cap | $3.46B | $3.29B |
| Today | +5.40% | +15.53% |
| 1 month | +11.5% | +59.5% |
| 6 months | +14.7% | +65.7% |
| Year to date | +206.8% | −6.6% |
| 1 year | +136.3% | +25.5% |
| Revenue growth (YoY) | — | +278.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −39726.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 46.3× |
| Net cash | $895.2M | $625.7M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 55.5% |
| Short % of float | 16.4% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).